logo
Women who work night shifts are more likely to have THIS disease

Women who work night shifts are more likely to have THIS disease

Time of India8 hours ago

A UK study reveals a health concern. Women working night shifts face a higher risk of asthma. The research, involving over 270,000 people, highlights this gender-specific link. Researchers at the University of Manchester led the study. They found no similar connection in men. The findings suggest a need for further investigation. Experts propose exploring hormonal and occupational factors.
I
n a world that never sleeps, humans, too, have adapted to live and work around the clock. Just like men, women often find themselves working odd shifts, including the night shift.
But guess what? Although such odd shifts may benefit their careers, they also come with numerous health risks. Women on night shifts are especially prone to illnesses. A new study found that women who work night shifts are more likely to suffer from asthma compared to those who work in the regular daytime.
Drawbacks of women working night shifts
The study is led by researchers at the University of Manchester, UK. The findings are published in the
ERJ Open Research.
The study involved more than 270,000 people and found that women working night shifts are more likely to suffer from moderate or severe asthma.
However, they found no such link between asthma and working night shifts in men.
Dr Robert Maidstone, the lead researcher, in a statement, said, 'Asthma disproportionately affects women. Women generally have more severe asthma, and a higher rate of hospitalisation and death from asthma compared to men. In our previous research, we found a higher risk of moderate or severe asthma in nightshift workers, so we wanted to see whether there were further differences between the sexes.'
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Eat 1 Teaspoon Every Night, See What Happens A Week Later [Video]
getfittoday
Undo
The study
To investigate the relationship between night shifts and asthma in women, the researchers utilized data from the UK Biobank. They looked at 274,541 working people and found that 5.3% of these had
asthma
, with 1.9% suffering from moderate or severe asthma (meaning they were taking an asthma preventer inhaler and at least one other asthma treatment, such as an oral steroid). The researchers divided the women into three categories - those who worked only during the day, only nightshifts, or a combination of the two.
What did they find
The findings were shocking. They found that women who work shifts are more likely to have asthma. Women who only work night shifts were around 50% more likely to suffer from moderate or severe asthma compared to those who work in the daytime.
'This is the first study to evaluate sex differences in the relationship between shift work and asthma. We found that permanent night shift workers had higher odds of moderate-severe asthma when compared to corresponding day workers.
This type of research cannot explain why shift work and asthma are linked; however, it could be because shift work disrupts the body clock, including the levels of male and female sex hormones.
High testosterone has previously been shown to be protective against asthma, and so lower testosterone in women could play a role. Alternatively, men and women work different types of shift jobs, and this could be a factor,' Dr Maidstone said.
The researchers also found that the risk was almost double in postmenopausal women, compared to day workers, in those not taking hormone replacement therapy (HRT).
King Charles' Cancer CONFIRMED As 'Incurable'? Royal Health Secret Finally Revealed | Shocking Update
'Our results suggest that HRT might be protective against asthma for nightshift workers; however, further research is needed to test this hypothesis in prospective studies and randomised controlled trials,' Dr Maidstone added.
'Asthma is a common, long-term condition that affects millions of people worldwide. We know that women are more likely to have asthma, to have worse asthma, and are more likely to die from asthma, but we do not fully understand why. This research suggests that working night shifts could be a risk factor for asthma in women, but not in men. The majority of workers will not have an easy option of switching their shift pattern, so we need further research to verify and understand this link and find out what could be done to reduce the risk for women who work shifts,' Professor Florence Schleich from the European Respiratory Society's expert group on airway diseases, asthma, COPD and chronic cough, who is not part of the research commented.
One step to a healthier you—join Times Health+ Yoga and feel the change

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NASA's James Webb Space Telescope uncovers mysterious ‘climate system' on Pluto regulated by strange blue haze
NASA's James Webb Space Telescope uncovers mysterious ‘climate system' on Pluto regulated by strange blue haze

Time of India

time33 minutes ago

  • Time of India

NASA's James Webb Space Telescope uncovers mysterious ‘climate system' on Pluto regulated by strange blue haze

Source: Live Science NASA 's James Webb Space Telescope is again on its way to expand the understanding of the outer solar system. And this time, the explanation on its dwarf planet Pluto that keeps defying expectations. Nearly a decade earlier, NASA's New Horizons spacecraft shattered the notion of the upended assumptions about Pluto's lifelessness, where new data revealed by JWST confirms something extraordinary. One of the biggest surprises which floated above all is Pluto's blueish haze, which isn't just a visual marvel but actively regulates the planet's climate. With James Webb Space Telescope data-gathering in full swing, astronomers hope to study other hazy bodies in the solar system and beyond. The success of this Pluto study may lead to new models of climate formation on exoplanets with thick, layered atmospheres. NASA's James Webb Space Telescope uncovers Pluto's mysterious climate system When NASA's New Horizons spacecraft flew past Pluto in 2015, it shattered the image of Pluto as a dull, frozen rock. Instead, it unveiled a dynamic world marked by vast icy plains, mountain ranges made of water ice, and most intriguingly, a bluish, multi-layered haze that enveloped the planet. This haze extended more than 185 miles (300 km) above Pluto's surface, surprising scientists with its complexity and reach. The discovery hinted that Pluto might have a more active atmosphere than previously believed — but at the time, its true impact remained uncertain. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo Pluto's haze role in climate regulation revealed Astronomers have now confirmed that Pluto's haze does more than decorate the sky, dedicatedly thanks to the infrared capabilities of JWST. This significantly cools the atmosphere. According to a study published in Nature Astronomy on June 2, this haze absorbs sunlight during the day and releases it as infrared radiation at night, effectively regulating the dwarf planet's temperature. 'This is unique in the solar system,' said Tanguy Bertrand, the study's lead author and an astronomer at the Paris Observatory. 'It's a new kind of climate.' Pluto's haze composition Pluto's haze is composed of complex organic molecules known as tholins, which form when ultraviolet sunlight breaks down methane and nitrogen in the upper atmosphere. These particles then clump together into tiny haze layers that can trap and release heat. Back in 2017, planetary scientists proposed that this haze might be behind Pluto's unusually cold upper atmosphere measured at about -333°F (-203°C), or roughly 30 degrees cooler than models based on gas-only atmospheres had predicted. The idea was compelling, but proving it was another matter entirely. James Webb Space Telescope confirms Pluto's climate theory by separating signals from its Moon One major challenge in confirming the theory was Charon, Pluto's large moon, which orbits so closely that its thermal signal overlaps with Pluto's in most telescope data. This made it nearly impossible to isolate the haze's specific thermal impact. That changed with James Webb Space Telescope. In 2022, its superior infrared resolution allowed researchers to separate the emissions from Pluto and Charon. What they found confirmed the 2017 hypothesis: Pluto's mid-infrared brightness which is caused by its haze and perfectly matched earlier predictions. 'In planetary science, it's not common to have a hypothesis confirmed so quickly,' said Xi Zhang, who led the 2017 study. 'We feel pretty lucky and very excited.' What Pluto's skies reveal about the origins of life on Earth The discovery isn't just a milestone for understanding Pluto but it also opens up new possibilities for studying other hazy celestial bodies. Moons like Titan (Saturn) and Triton (Neptune) are shrouded in their own thick hazes and may exhibit similar atmospheric behaviors. Researchers even suggest that early Earth might have once resembled Pluto. Before oxygen filled our skies, Earth may have had a tholin-rich haze that acted like an insulating blanket, helping stabilize the climate and create conditions that allowed life to evolve. 'By studying Pluto's haze and chemistry,' Zhang said, 'we might get new insights into the conditions that made early Earth habitable.' Also Read | Why the US leads in UFO sightings; here's the surprising truth behind the numbers revealed

Now a cholesterol pill to cut down the risk of a heart attack? New study reveals ‘hopeful' results
Now a cholesterol pill to cut down the risk of a heart attack? New study reveals ‘hopeful' results

Time of India

time34 minutes ago

  • Time of India

Now a cholesterol pill to cut down the risk of a heart attack? New study reveals ‘hopeful' results

Imagine a building block that your body needs for building cells, making hormones, and aiding digestion. Now, think of a situation where the are so many building blocks that it becomes overcrowded, and instead of helping your body – the buildup of plaque in arteries and block the way of the heart functioning properly. Cholesterol works exactly like that. Cholesterol is a waxy substance your body needs for building cells, making hormones, and aiding digestion. But if you have too much cholesterol in your blood (high cholesterol), it can build up in your arteries, potentially leading to heart disease and other health issues. Now, a research trial has come up with a groundbreaking daily pill, a potentially simpler and more convenient method for managing high cholesterol levels, ultimately aiming to reduce the risk of heart attacks and strokes. Read on to know more. What is cholesterol? Cholesterol is essential for building healthy cells and producing hormones, vitamin D, and substances that aid digestion. Your liver produces all the cholesterol your body needs, but you also get it from animal-based foods. While cholesterol is necessary, too much can lead to health problems like heart disease. There are two main types of cholesterol: HDL (High-Density Lipoprotein): Known as "good" cholesterol, it helps remove excess cholesterol from your bloodstream. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Switch to UnionBank Rewards Card UnionBank Credit Card Apply Now Undo LDL (Low-Density Lipoprotein): Often called "bad" cholesterol, it can build up in arteries, leading to plaque and potential blockages. Now, there is a strong link between cholesterol and heart disease. High levels of LDL ("bad") cholesterol in the blood can lead to plaque buildup in arteries, narrowing them and potentially causing heart attacks or strokes. While the body naturally produces cholesterol, dietary sources like saturated and trans fats can contribute to high levels, increasing heart disease risk. In order to manage cholesterol levels, one must adhere to a proper diet, regular exercise, and sometimes medication. The new study came up with this innovative medication, named Obicetrapib, which has recently been evaluated in a comprehensive Phase 3 clinical trial conducted at Monash University in Australia. Insight into the study and the medicine: The trial featured over 2,500 participants, with an average age of 65 years, all of whom had either been diagnosed with heart disease or exhibited genetically elevated cholesterol levels. According to a press release from the university, each participant was already on the "maximum tolerated doses" of traditional cholesterol-lowering therapies before enrolling in the study. In a controlled setting, one group of participants received Obicetrapib, while the other group was administered a placebo, all while continuing their existing cholesterol medications. Astonishing results emerged after just 12 weeks: those taking Obicetrapib exhibited a remarkable 32.6% reduction in low-density lipoprotein (LDL) cholesterol, often referred to as "bad cholesterol," and a significant 33.5% decrease in lipoprotein(a) [Lp(a)], a type of protein linked to heart disease risk. These compelling findings were shared at the recent European Atherosclerosis Society Congress held in the United Kingdom, and they were also published in the esteemed medical journal, The New England Journal of Medicine . Professor Stephen Nicholls, the study's lead and director of Monash University's Victorian Heart Institute and its associated Victorian Heart Hospital, highlighted a critical insight: 'We are aware that many individuals at high risk for heart attack or stroke fail to reach optimal cholesterol levels, even when utilizing the best available treatments.' Professor Nicholls emphasized the potential of Obicetrapib, stating that not only did it effectively lower LDL cholesterol by over 30%, but it also induced a noteworthy reduction in Lp(a), which poses a formidable challenge in treatment and is notably associated with increased heart disease risk. LDL cholesterol has become synonymous with adverse cardiovascular outcomes when present in excessive amounts, as it can accumulate in blood vessels, eventually heightening the likelihood of heart attacks and strokes. Conversely, lipoprotein(a), or Lp(a), is a genetically inherited protein; unlike LDL, its levels cannot be modified through lifestyle changes or conventional medications. The researchers reported that Obicetrapib was "well-tolerated" among the trial participants, suggesting a favorable safety profile for this new option. Professor Nicholls remarked, 'This could be a valuable tool in the ongoing battle against heart disease. It offers convenience and efficacy, addressing a critical gap for patients who have exhausted available therapeutic options.' The limitations: However, the study did acknowledge certain limitations. For instance, participants were not specifically selected based on elevated Lp(a) levels, meaning the effects of the drug on this particular subgroup remain unclear. Additionally, while notable alterations in LDL levels were documented, the study did not track actual occurrences of heart attacks or strokes. To strengthen understanding of Obicetrapib's long-term efficacy and safety, further studies are deemed essential, particularly those that include diverse patient populations and follow them over extended periods. New study shows link between high cholesterol, heart disease 'inconsistent' One step to a healthier you—join Times Health+ Yoga and feel the change

Magnesium myths: What you don't know could be making you tired
Magnesium myths: What you don't know could be making you tired

Time of India

timean hour ago

  • Time of India

Magnesium myths: What you don't know could be making you tired

Magnesium doesn't make headlines like Vitamin D or Iron, but it quietly keeps your muscles, brain, and energy systems running. Often called the 'master mineral,' it's involved in over 300 bodily functions, yet most people don't know much about it—except that it shows up in wellness ads and supplement shelves. Here's the truth behind the most common magnesium myths—and what your body actually needs. Myth 1: 'If I eat healthy, I'm getting enough magnesium.' Fact: Magnesium is present in nuts, seeds, leafy greens, bananas, and even dark chocolate. But even a clean diet may not meet your needs today. Modern soil depletion, food processing, and gut absorption issues (especially in people with IBS, celiac, or acid reflux on long-term medication) mean many fall short despite good intentions. That said, food should still be your first line of defence, not supplements. Myth 2: 'Everyone needs to take a magnesium supplement.' Fact: Not necessarily. This belief is not only incorrect—it can be risky. Too much magnesium from supplements can cause loose stools, low blood pressure, or more serious complications in people with kidney issues. Supplements aren't harmless 'vitamins'—they are concentrated forms of a mineral and should only be used if there's a known deficiency or specific medical need, not because they're trending. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Switch to UnionBank Rewards Card UnionBank Credit Card Apply Now Undo A blood test or clinical evaluation can help you decide what your body actually requires. Myth 3: 'All magnesium supplements are created equal.' Fact: There are several types of magnesium, each with different roles and absorption levels. Magnesium oxide is poorly absorbed but useful for constipation. Magnesium citrate is better for mild supplementation and digestion. Magnesium glycinate is known for its calming effects and is often recommended for stress, sleep issues, or muscle recovery. Then there's magnesium threonate, which crosses the blood-brain barrier and is being explored for memory and focus. Choosing the wrong type could mean wasting your money—or upsetting your stomach. Myth 4: 'Magnesium will knock you out at night.' Fact: Magnesium isn't a sedative—it doesn't put you to sleep like a pill. Instead, it helps regulate neurotransmitters like GABA that promote calm and relaxation. If your magnesium is low, you might feel anxious or restless. Supplementing can help restore balance, but it's more like smoothing the edges of your stress—not flipping an off switch. Myth 5: 'If it's natural, more is better.' Fact: Your body is smarter than that. Magnesium needs to be in balance with other minerals like calcium and potassium. Overdoing it—especially without supervision—can throw things off. For most people, starting with magnesium-rich foods like pumpkin seeds, spinach, almonds, or even a banana at bedtime is safe and effective. Supplements should be a second step, not a shortcut. Know before you dose Magnesium is crucial—but misunderstood. Before reaching for a supplement, consider what's on your plate. If you're tired, tense, or struggling to sleep, talk to a doctor first. A simple blood test or even a dietary review may reveal what's missing—and how to fix it naturally. In the case of magnesium, less hype and more personalized care goes a long way. Dr Sandeep Reddy Koppula, HOD - Internal Medicine, Arete Hospitals One step to a healthier you—join Times Health+ Yoga and feel the change

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store